Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.

Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, DeWeese TL, Song DY, Wang H, Carducci MA, Pienta KJ, Pomper MG, Dicker AP, Eisenberger MA, Alizadeh AA, Diehn M, Tran PT.

JAMA Oncol. 2020 Mar 26. doi: 10.1001/jamaoncol.2020.0147. [Epub ahead of print]

PMID:
32215577
2.

Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer.

Deek MP, Tran PT.

Cancer J. 2020 Mar/Apr;26(2):137-143. doi: 10.1097/PPO.0000000000000432.

PMID:
32205538
3.

Emerging Role of Circulating Tumor Cells in Gastric Cancer.

Thanh Huong P, Gurshaney S, Thanh Binh N, Gia Pham A, Hoang Nguyen H, Thanh Nguyen X, Pham-The H, Tran PT, Truong Vu K, Xuan Duong N, Pelucchi C, La Vecchia C, Boffetta P, Nguyen HD, Luu HN.

Cancers (Basel). 2020 Mar 15;12(3). pii: E695. doi: 10.3390/cancers12030695. Review.

4.

Impact of the Astaxanthin, Betanin, and EGCG Compounds on Small Oligomers of Amyloid Aβ40 Peptide.

Minh Hung H, Nguyen MT, Tran PT, Truong VK, Chapman J, Quynh Anh LH, Derreumaux P, Vu VV, Ngo ST.

J Chem Inf Model. 2020 Mar 23;60(3):1399-1408. doi: 10.1021/acs.jcim.9b01074. Epub 2020 Mar 10.

PMID:
32105466
5.

Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer.

Tran PT, Diaby V.

J Manag Care Spec Pharm. 2020 Feb;26(2):221. doi: 10.18553/jmcp.2020.26.2.221.

6.

Radiotherapy in the Management of Metastatic Hormone-Sensitive Prostate Cancer: What Is the Standard of Care?

Deek MP, Phillips R, Tran PT.

Cancer J. 2020 Jan/Feb;26(1):87-93. doi: 10.1097/PPO.0000000000000429.

PMID:
31977391
7.

Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries.

De Bruycker A, Tran PT, Achtman AH, Ost P; GAP6 consortium.

World J Urol. 2020 Jan 18. doi: 10.1007/s00345-019-03063-4. [Epub ahead of print]

PMID:
31955223
8.

New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity.

Huan LC, Anh DT, Truong BX, Duc PH, Hai PT, Duc-Anh L, Huong LT, Park EJ, Lee HJ, Kang JS, Tran PT, Thanh Hai DT, Kim Oanh DT, Han SB, Nam NH.

Chem Biodivers. 2020 Mar;17(3):e1900670. doi: 10.1002/cbdv.201900670. Epub 2020 Feb 4.

PMID:
31943757
9.

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity.

Dhanasekaran R, Baylot V, Kim M, Kuruvilla S, Bellovin DI, Adeniji N, Rajan Kd A, Lai I, Gabay M, Tong L, Krishnan M, Park J, Hu T, Barbhuiya MA, Gentles AJ, Kannan K, Tran PT, Felsher DW.

Elife. 2020 Jan 14;9. pii: e50731. doi: 10.7554/eLife.50731.

10.

Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial.

Fox GJ, Nguyen CB, Nguyen TA, Tran PT, Marais BJ, Graham SM, Nguyen BH, Velen K, Dowdy DW, Mason P, Britton WJ, Behr MA, Benedetti A, Menzies D, Nguyen VN, Marks GB.

BMJ Open. 2020 Jan 2;10(1):e033945. doi: 10.1136/bmjopen-2019-033945.

11.

Appropriateness of Otic Quinolone Use among Privately Insured US Patients.

Tran PT, Winterstein AG, Wang X, Rhew K, Antonelli PJ.

Otolaryngol Head Neck Surg. 2020 Jan;162(1):102-107. doi: 10.1177/0194599819889607. Epub 2019 Nov 19.

PMID:
31743076
12.

Complex Class 1 Integron in a Clinical Escherichia coli Strain From Vietnam Carrying Both mcr-1 and bla NDM-1.

Le-Vo HN, Tran PT, Le L, Matsumoto Y, Motooka D, Nakamura S, Jones JW, Iida T, Cao V.

Front Microbiol. 2019 Oct 31;10:2472. doi: 10.3389/fmicb.2019.02472. eCollection 2019.

13.

Developments in oligometastatic hormone-sensitive prostate cancer.

Tran PT, Ost P.

World J Urol. 2019 Dec;37(12):2545-2547. doi: 10.1007/s00345-019-03009-w. No abstract available.

PMID:
31705198
14.

Metastasis-Directed Therapy in Prostate Cancer. Why, When, and How?

Phillips RM, Deek MP, Deweese TL, Tran PT.

Oncology (Williston Park). 2019 Oct 28;33(10). pii: 686509.

15.

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer.

Ross AE, Hurley PJ, Tran PT, Rowe SP, Benzon B, Neal TO, Chapman C, Harb R, Milman Y, Trock BJ, Drake CG, Antonarakis ES.

Prostate Cancer Prostatic Dis. 2020 Mar;23(1):184-193. doi: 10.1038/s41391-019-0176-8. Epub 2019 Oct 14.

PMID:
31611635
16.

Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design, synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.

Huan LC, Tran PT, Phuong CV, Duc PH, Anh DT, Hai PT, Huong LTT, Thuan NT, Lee HJ, Park EJ, Kang JS, Linh NP, Hieu TT, Oanh DTK, Han SB, Nam NH.

Bioorg Chem. 2019 Nov;92:103202. doi: 10.1016/j.bioorg.2019.103202. Epub 2019 Aug 14.

PMID:
31479984
17.

Prediction of AChE-ligand affinity using the umbrella sampling simulation.

Lan NT, Vu KB, Dao Ngoc MK, Tran PT, Hiep DM, Tung NT, Ngo ST.

J Mol Graph Model. 2019 Dec;93:107441. doi: 10.1016/j.jmgm.2019.107441. Epub 2019 Aug 27.

PMID:
31479951
18.

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma.

Jafarnejad M, Sové RJ, Danilova L, Mirando AC, Zhang Y, Yarchoan M, Tran PT, Pandey NB, Fertig EJ, Popel AS.

NPJ Syst Biol Appl. 2019 Aug 16;5:29. doi: 10.1038/s41540-019-0107-2. eCollection 2019.

19.

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.

Deek MP, Yu C, Phillips R, Song DY, Deville C, Greco S, DeWeese TL, Antonarakis ES, Markowski M, Paller C, Denmeade S, Carducci M, Walsh PC, Pienta KJ, Eisenberger M, Tran PT.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):948-956. doi: 10.1016/j.ijrobp.2019.08.008. Epub 2019 Aug 13.

20.

Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design.

Hoang VH, Ngo VTH, Cui M, Manh NV, Tran PT, Ann J, Ha HJ, Kim H, Choi K, Kim YH, Chang H, Macalino SJY, Lee J, Choi S, Lee J.

J Med Chem. 2019 Sep 12;62(17):8011-8027. doi: 10.1021/acs.jmedchem.9b00751. Epub 2019 Aug 27.

PMID:
31411468
21.

The Effects of 2',4'-Dihydroxy-6'-methoxy-3',5'- dimethylchalcone from Cleistocalyx operculatus Buds on Human Pancreatic Cancer Cell Lines.

Tuan HN, Minh BH, Tran PT, Lee JH, Oanh HV, Ngo QMT, Nguyen YN, Lien PTK, Tran MH.

Molecules. 2019 Jul 11;24(14). pii: E2538. doi: 10.3390/molecules24142538.

22.

Hook3 is a scaffold for the opposite-polarity microtubule-based motors cytoplasmic dynein-1 and KIF1C.

Kendrick AA, Dickey AM, Redwine WB, Tran PT, Vaites LP, Dzieciatkowska M, Harper JW, Reck-Peterson SL.

J Cell Biol. 2019 Sep 2;218(9):2982-3001. doi: 10.1083/jcb.201812170. Epub 2019 Jul 18.

23.

Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer.

Nguyen TQ, Bui TO, Tran PT, Tran VT, Nguyen VH, Chu QH, Bui TAT, Le NQ, Le VQ, Dao VT.

Cancer Control. 2019 Jan-Dec;26(1):1073274819864111. doi: 10.1177/1073274819864111.

24.

α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.

van Hout M, Valdes A, Christensen SB, Tran PT, Watkins M, Gajewiak J, Jensen AA, Olivera BM, McIntosh JM.

Neuropharmacology. 2019 Oct;157:107691. doi: 10.1016/j.neuropharm.2019.107691. Epub 2019 Jun 28.

PMID:
31255696
25.

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).

Kapoor R, Deek MP, McIntyre R, Raman N, Kummerlowe M, Chen I, Gaver M, Wang H, Denmeade S, Lotan T, Paller C, Markowski M, Carducci M, Eisenberger M, Beer TM, Song DY, DeWeese TL, Hearn JW, Greco S, DeVille C, Desai NB, Heath EI, Liauw S, Spratt DE, Hung AY, Antonarakis ES, Tran PT.

BMC Cancer. 2019 Jun 13;19(1):572. doi: 10.1186/s12885-019-5805-z.

26.

Characterization of a carbapenem- and colistin-resistant Enterobacter cloacae carrying Tn6901 in bla NDM-1 genomic context.

Le-Ha TD, Le L, Le-Vo HN, Anda M, Motooka D, Nakamura S, Tran LK, Tran PT, Iida T, Cao V.

Infect Drug Resist. 2019 Apr 3;12:733-739. doi: 10.2147/IDR.S194495. eCollection 2019.

27.

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer.

Kishan AU, Tendulkar RD, Tran PT, Parker CC, Nguyen PL, Stephenson AJ, Carrie C.

Eur Urol Oncol. 2018 May;1(1):3-18. doi: 10.1016/j.euo.2018.02.008. Epub 2018 May 15. Review.

PMID:
31100226
28.

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.

Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C Jr, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.

Eur Urol. 2020 Jan;77(1):3-10. doi: 10.1016/j.eururo.2019.03.022. Epub 2019 Apr 13.

PMID:
30992160
29.

Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.

Tran PT, Dang NH, Kim O, Van Cuong P, Dat NT, Hwangbo C, Van Minh C, Lee JH.

Phytomedicine. 2019 Jun;59:152908. doi: 10.1016/j.phymed.2019.152908. Epub 2019 Apr 2.

PMID:
30981187
30.

Diterpenoids isolated from the root of Salvia miltiorrhiza and their anti-inflammatory activity.

Ngo TM, Tran PT, Hoang LS, Lee JH, Min BS, Kim JA.

Nat Prod Res. 2019 Apr 9:1-7. doi: 10.1080/14786419.2019.1596098. [Epub ahead of print]

PMID:
30961363
31.

Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.

Phillips RM, Lam C, Wang H, Tran PT.

Adv Cancer Res. 2019;142:23-62. doi: 10.1016/bs.acr.2019.01.002. Epub 2019 Feb 27.

PMID:
30885363
32.

Secrecy Performance of TAS/SC-Based Multi-Hop Harvest-to-Transmit Cognitive WSNs Under Joint Constraint of Interference and Hardware Imperfection.

Tin PT, Minh Nam P, Trung Duy T, Tran PT, Voznak M.

Sensors (Basel). 2019 Mar 7;19(5). pii: E1160. doi: 10.3390/s19051160.

33.

Verrucous melanoma masquerading as a seborrheic keratosis.

Tran PT, Truong AK, Munday W, Alexanian S, Levins P.

Dermatol Online J. 2019 Feb 15;25(2). pii: 13030/qt1m07k7fm.

34.

Quantifying Tubulin Concentration and Microtubule Number Throughout the Fission Yeast Cell Cycle.

Loiodice I, Janson ME, Tavormina P, Schaub S, Bhatt D, Cochran R, Czupryna J, Fu C, Tran PT.

Biomolecules. 2019 Mar 4;9(3). pii: E86. doi: 10.3390/biom9030086.

35.

Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.

Marciscano AE, Haimovitz-Friedman A, Lee P, Tran PT, Tomé WA, Guha C, Spring Kong FM, Sahgal A, El Naqa I, Rimner A, Marks LB, Formenti SC, DeWeese TL.

Int J Radiat Oncol Biol Phys. 2019 Mar 2. pii: S0360-3016(19)30290-1. doi: 10.1016/j.ijrobp.2019.02.046. [Epub ahead of print] No abstract available.

PMID:
30836168
36.

Kinesin-6 regulates cell-size-dependent spindle elongation velocity to keep mitosis duration constant in fission yeast.

Krüger LK, Sanchez JL, Paoletti A, Tran PT.

Elife. 2019 Feb 26;8. pii: e42182. doi: 10.7554/eLife.42182.

37.

Hereditary Spherocytosis Presenting as Diffuse Bone Marrow Activation and Splenomegaly on PSMA-Targeted 18F-DCFPyL PET/CT.

Gomez E, Tran PT, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Clin Nucl Med. 2019 Apr;44(4):e313-e314. doi: 10.1097/RLU.0000000000002489.

38.

Author's view: epithelial plasticity metabolically reprograms normal cells towards a neoplastic-prone state.

Wang H, Tran PT.

Mol Cell Oncol. 2018 Dec 24;6(1):1543485. doi: 10.1080/23723556.2018.1543485. eCollection 2019.

39.

Structure-activity relationship of leucyladenylate sulfamate analogues as leucyl-tRNA synthetase (LRS)-targeting inhibitors of Mammalian target of rapamycin complex 1 (mTORC1).

Yoon S, Kim SE, Kim JH, Yoon I, Tran PT, Ann J, Kim C, Byun WS, Lee S, Kim S, Lee J, Lee J.

Bioorg Med Chem. 2019 Mar 15;27(6):1099-1109. doi: 10.1016/j.bmc.2019.01.037. Epub 2019 Jan 30.

PMID:
30755350
40.

(E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.

Huan LC, Phuong CV, Truc LC, Thanh VN, Pham-The H, Huong LT, Thuan NT, Park EJ, Ji AY, Kang JS, Han SB, Tran PT, Nam NH.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):465-478. doi: 10.1080/14756366.2018.1555536.

41.

Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.

Mu W, Muriello M, Clemens JL, Wang Y, Smith CH, Tran PT, Rowe PC, Francomano CA, Kline AD, Bodurtha J.

Am J Med Genet A. 2019 Apr;179(4):561-569. doi: 10.1002/ajmg.a.61055. Epub 2019 Jan 31.

42.

Individual and Occupational Differences in Perceived Organisational Culture of a Central Hospital in Vietnam.

Nguyen Van H, Nguyen ATH, Nguyen TTH, Nguyen HTT, Bui HTT, Tran PT, Nguyen ALT.

Biomed Res Int. 2018 Dec 24;2018:3759290. doi: 10.1155/2018/3759290. eCollection 2018.

43.

Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.

Tran PT, Dat NT, Dang NH, Van Cuong P, Lee S, Hwangbo C, Van Minh C, Lee JH.

Phytomedicine. 2019 Mar 1;55:1-8. doi: 10.1016/j.phymed.2018.10.029. Epub 2018 Oct 25.

PMID:
30668419
44.

Degalactotigonin, a Steroidal Glycoside from Solanum nigrum, Induces Apoptosis and Cell Cycle Arrest via Inhibiting the EGFR Signaling Pathways in Pancreatic Cancer Cells.

Tuan Anh HL, Tran PT, Thao DT, Trang DT, Dang NH, Van Cuong P, Kiem PV, Minh CV, Lee JH.

Biomed Res Int. 2018 Dec 16;2018:3120972. doi: 10.1155/2018/3120972. eCollection 2018.

45.

What Is Oligometastatic Prostate Cancer?

Fraser M, Koontz B, Emmenegger U, De Meerleer G, Khoo V, Feng F, Corcoran NM, Hovens CM, Tran PT, Ost P, Boutros PC; GAP6 Consortium.

Eur Urol Focus. 2019 Mar;5(2):159-161. doi: 10.1016/j.euf.2018.12.009. Epub 2019 Jan 12. Review.

PMID:
30642810
46.

A plant intron enhances the performance of an infectious clone in planta.

Tran PT, Fang M, Widyasari K, Kim KH.

J Virol Methods. 2019 Mar;265:26-34. doi: 10.1016/j.jviromet.2018.12.012. Epub 2018 Dec 19.

PMID:
30578897
47.

Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system.

Maxwell R, Luksik AS, Garzon-Muvdi T, Hung AL, Kim ES, Wu A, Xia Y, Belcaid Z, Gorelick N, Choi J, Theodros D, Jackson CM, Mathios D, Ye X, Tran PT, Redmond KJ, Brem H, Pardoll DM, Kleinberg LR, Lim M.

Oncoimmunology. 2018 Sep 6;7(12):e1500108. doi: 10.1080/2162402X.2018.1500108. eCollection 2018.

48.

Clinical Development of Novel Drug-Radiotherapy Combinations.

Ahmad SS, Crittenden MR, Tran PT, Kluetz PG, Blumenthal GM, Bulbeck H, Baird RD, Williams KJ, Illidge T, Hahn SM, Lawrence TS, Spears PA, Walker AJ, Sharma RA.

Clin Cancer Res. 2019 Mar 1;25(5):1455-1461. doi: 10.1158/1078-0432.CCR-18-2466. Epub 2018 Nov 29.

49.

Correction to: Anti-inflammatory activity of caffeic acid derivatives isolated from the roots of Salvia miltiorrhiza Bunge.

Choi HG, Tran PT, Lee JH, Min BS, Kim JA.

Arch Pharm Res. 2019 Apr;42(4):378. doi: 10.1007/s12272-018-1090-7.

PMID:
30456742
50.

Local failure is a dominant mode of recurrence in locally advanced and clinical node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy.

Hayman J, Hole KH, Seierstad T, Perin J, DeWeese TL, Tran PT, Lilleby W.

Urol Oncol. 2019 Apr;37(4):289.e19-289.e26. doi: 10.1016/j.urolonc.2018.09.016. Epub 2018 Nov 13.

PMID:
30446451

Supplemental Content

Support Center